Intrasense laatste nieuws nabeurs:
Montpellier, April 21st 2020 – 06h00 PM CEST
CE marking for the CT protocol dedicated to COVID-19
Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions and designer of Myrian, announces that the scanner reading protocol dedicated to COVID-19 has obtained its CE marking as a world premiere.
A medical device for use in clinical routine
Now Class IIa medical device, the CE marking is a major step offering an even wider use of the solution. Useful for all key stages of the fight against the epidemic, from screening to clinical follow-up through the analysis of the pathological stage, the protocol allows an objective and precise quantification of the patient's pulmonary stage, optimizing adaptation of therapeutic response.
Its deployment in clinical routine completes its use in clinical studies and trials for drug and treatment evaluations.
This step allows a real mass deployment of the solution both in Europe, thanks to this CE marking, but also in the United States, most affected country by the pandemic, thanks to the FDA authorization.
Large scale deployment
With currently more than 350 requests from hospitals and clinics worldwide for this specific solution, Intrasense continues to position itself as a reference player in medical imaging, supporting healthcare professionals during this health crisis. Key contacts have been initiated at the highest levels in Europe and the United States for a massive deployment on these continents.
Any interested healthcare professional, hospital or clinic can obtain the solution free of charge by simply filling in the form on the company’s website.